Detailed interim results will soon be shared through scientific channels.

Human immunodeficiency virus (HIV) is an RNA (ribonucleic acid) virus that infects human immune cells, in particular CD4 T lymphocytes and is acquired through mucosal or intravenous...

NIH leadership calls for population-specific considerations in study design.

Study suggests greater CD8+ T-cell activity may increase HIV immunity.

The investigators believe their study shows that very early ART is safe and is key to suppressing HIV to undetectable levels during early childhood periods of rapid growth.

New study published in the journal Cell Reports.

Update from HHS.

Novel vaccine includes NIH-funded technology in development since 2004.

WHO update.

Long-term evaluation bolsters support that being a donor is safe for people living with HIV, making it possible to extend life for their recipients.